Diastolic dysfunction is common in infants and neonates with left ventricular (LV) outflow tract obstruction and may lead to low-cardiac output in the postoperative period. We present a management strategy for severe postrepair diastolic dysfunction in an infant with critical congenital aortic stenosis and LV hypertrophy, employing β-blockade and levosimendan.
LamYYKayaMGLiWGatzoulisMAHeneinMY. Effect of chronic afterload increase on left ventricular myocardial function in patients with congenital left sided obstructive lesions. Am J Cardiol. 2007;99(11):1582–1587.
2.
FriedmanKGMargossianRGrahamDA. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am J Cardiol. 2011;108(4):556–560.
3.
HeinSArnonEKostinS. Progression from compensated hypertrophy to failure in the pressure overloaded human heart:structural deterioration and compensatory mechanism. Circulation. 2003;107(7):984–991.
4.
BernardFDenaultABabinD. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg. 2001;92(2):291–298.
5.
ZileMRBrutsaertDL. New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation. 2002;105(12):1503–1508.
6.
RanasingheIYeohTYiannikasJ. Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric hypertrophy. Heart Lung Circ. 2011;20(9):579–586.
7.
HasenfussGPeiskeBCastellMKretschmannBMaierLSJustH. Influence of the novel ionotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 1998;98(20):2141–2147.
